Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.87M
-
Shares change
-
-36K
-
Total reported value, excl. options
-
$2.05M
-
Value change
-
-$115K
-
Put/Call ratio
-
0
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$1.10
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2022
16 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q2 2022.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.87M shares
of 101M outstanding shares and own 1.84% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (1.2M shares), VANGUARD GROUP INC (465K shares), GEODE CAPITAL MANAGEMENT, LLC (80.7K shares), EMC Capital Management (55.1K shares), RAYMOND JAMES & ASSOCIATES (20K shares), RENAISSANCE TECHNOLOGIES LLC (18.2K shares), NORTHERN TRUST CORP (10.6K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (9.3K shares), Tower Research Capital LLC (TRC) (6.91K shares), and JPMORGAN CHASE & CO (0 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.